InvestorsHub Logo
Followers 40
Posts 3318
Boards Moderated 0
Alias Born 08/18/2009

Re: zj3001 post# 4392

Wednesday, 10/12/2016 3:46:04 PM

Wednesday, October 12, 2016 3:46:04 PM

Post# of 8449
That's my assumption yes.. that because of the generics that will compete (albeit with a major disadvantage), KIT-302 seems (to me) unlikely to get to Celebrex's peak. But hey.. I'm certainly open to other opinions -- that's why I'm here .. to learn from others.

Maybe their market study, or the research paper by LifeSci Capital, has me tempering my enthusiasm. wink

In any case, I'm long and very bullish.